Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • My Role
  • Membership
  • Learning
  • Get Involved
  • Careers
  • About ASCP
  • Board of Certification
  • News
  • ASCP
  • Get Involved
  • Institute for Science Technology & Public Policy
  • Coronavirus 2019 (COVID-19) Resources
  • General Resources and Updates

COVID-19 Resources, Updates, and Events

Find links to key resources and updates regarding COVID-19 guidance, as well as information about events and on-demand recordings.

Clinical Resources
Payment & Reporting Resources
Career Resources
Grant Resources
Events & Recordings
Clinical Resources

Testing and Treatment Resources

Testing Resources

ASCP 2021 Comprehensive National COVID-19 Testing and Support Strategy 

ASCP 2020 National COVID-19 Diagnostic Testing and Support Strategy 

ASCP COVID-19 Recommendations - NEW! Recommendations added April 5, 2021 

FDA Policy for Diagnostic Tests for Coronavirus Disease-2019 During the Public Health Emergency

FDA FAQs on Diagnostic Testing for SARS-CoV-2

FDA Coronavirus Disease 2019 (COVID-19) In Vitro Diagnostics Emergency Use Authorizations 

CDC COVID-19 Information for Laboratories webpage

CDC Serology Testing for COVID-19 webpage

CDC Guidance on Postmortem Specimen Collection From Deceased Persons with Known or Suspected COVID-19 

CDC Interim Guidance for Rapid Antigen Testing for SARS-CoV-2 

CDC Guidance for SARS-CoV-2 Point-of-Care Testing 

CDC Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic, Screening, and Surveillance Testing 

CDC Guidance for Reporting SARS-CoV-2 Sequencing Results

ASCP Survey Data - Laboratory Staffing During COVID-19 Pandemic  

CDC Laboratory Training - Includes laboratory trainings relevant to COVID-19

Care and Treatment Resources

Duration of Isolation and Precautions for Adults with COVID-19

FDA Guidance Document - Investigational COVID-19 Convalescent Plasma: Guidance for Industry

COVIDPlasma.org - Includes information on the rapidly evolving therapy of COVID-19 convalescent plasma

Testing and Treatment Updates

CDC LOCS Lab Advisory: New Guidance for Reporting SARS-CoV-2 Sequencing Results (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

Biden COVID-19 Strategy Includes Key Elements of ASCP National Testing Strategy, and New Workforce Initiative (ASCP News)

CDC LOCS Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: CMS Updates CLIA Surveyor Guidance for SARS-CoV-2 Test Result Reporting (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: FDA Updates Reporting Guidance, Authorizes Update to IFU for CDC Influenza SARS-CoV-2 Multiplex Assay (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Alert: FDA Issues Safety Letter about Genetic Variants of SARS-CoV-2 and False Negative Results with Molecular Tests (CDC LOCS (Laboratory Outreach Communication System) Lab Alert)

CDC LOCS Lab Alert: FDA Issues Safety Letter about Genetic Variants of SARS-CoV-2 and False Negative Results with Molecular Tests (CDC LOCS (Laboratory Outreach Communication System) Lab Alert)

CDC LOCS Lab Advisory: FDA Authorizes Pooling for the CDC 2019-nCoV Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

COVID-19 Update: FDA Updates Antigen Template for Test Developers (FDA bulletin)

CDC LOCS Lab Advisory: CDC Publishes New Web Page on Point-of-Care Testing for COVID-19 (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Alert: FDA Suspends Review of EUA Requests for Laboratory-Developed Tests for SARS-CoV-2 (CDC LOCS (Laboratory Outreach Communication System) Lab Alert)

CMS Releases New Tools to Streamline Certification for Labs Testing for COVID-19 (CMS press release)

CDC LOCS Lab Advisory: LOINC In-Vitro Diagnostic (LIVD) Codes for SARS-CoV-2 Antigen Tests (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Update: New Clarification on Guidelines for Testing for SARS-CoV-2 (COVID-19) (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

CDC LOCS Laboratory Update: CMS Publishes New CLIA FAQs (CDC LOCS (Laboratory Outreach Communication System) Laboratory Update)

CDC LOCS Laboratory Alert: FDA Issues Safety Letter about Thermo Fisher Scientific TaqPath COVID-19 Combo Kit (CDC LOCS (Laboratory Outreach Communication System) Laboratory Alert)

CDC LOCS Lab Advisory: New COVID-19 Antigen Testing Guidance (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Update: FDA Issues COVID-19 Testing and Policy Updates  (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

CDC LOCS Lab Advisory: CDC Releases New Test Pooling Guidance for SARS-CoV-2 (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing (FDA news release)

CDC LOCS Lab Advisory: FDA Amends Instructions for Use of CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Update: FDA Updates Frequently Asked Questions about Testing for SARS-CoV-2 (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

CDC LOCS Lab Advisory: CDC Multiplex Assay Receives Authorization from FDA (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Update: FDA and CMS Update on Pooling for Diagnostic and Surveillance Testing for SARS-CoV-2 (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response (NIH news release)

CDC LOCS Lab Advisory: FDA Posts Information from Independent Evaluations of COVID-19 Serological Tests (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: CDC Releases Interim Guidance for Coronavirus Disease (COVID-19) Antibody Testing CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests (FDA news release)

CDC LOCS Lab Advisory: CDC Posts New Information about Serology Testing for COVID-19 (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

Antibody Test Oversight and Use for COVID-19 (FDA fact sheet)

FDA Voices: Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy (FDA Voices - Perspectives From FDA Leadership and Experts)

CDC LOCS Lab Advisory: CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

American Society for Clinical Pathology Urges Creation of National Pandemic Testing Task Force (ASCP News)

ASCP National Test Strategy Included in Legislation Passed by Senate (ASCP News)

Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers (FDA letter to health care providers)

CDC LOCS Lab Update: COVID-19 Laboratory Testing and Reporting Q&As and Specimen Collection Guidance (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

The American Society for Clinical Pathology Calls on the Federal Government to Develop a National COVID-19 Diagnostic Testing and Support Strategy (ASCP News)

CDC LOCS Lab Update: FDA Clarifies CLIA-waived Status for Point-of-Care SARS-CoV-2 Tests Under Emergency Use Authorizations (CDC LOCS (Laboratory Outreach Communication System) Lab Update)

Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic (FDA statement) Read an ASCP News story on this topic here.

Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency (CMS memorandum)

Coronavirus (COVID-19) Update: FDA Provides More Regulatory Relief During Outbreak, Continues to Help Expedite Availability of Diagnostics (FDA statement)

Hologic’s Molecular Test for the Novel Coronavirus, SARS-CoV-2, Receives FDA Emergency Use Authorization (Hologic press release)

Roche’s Cobas SARS-CoV-2 Test Receives FDA Emergency Use Authorization (Roche press release)

Laboratory Preparedness, Personal Protective Equipment (PPE), and Safety Resources

CDC Preparing and Supporting Laboratories Responding to COVID-19 webpage

CDC COVID-19 Infection Control and PPE Guidelines

CDC COVID-19 Healthcare Professionals: Frequently Asked Questions and Answers – Includes information related to transmission and waste management

SHEA (The Society for Healthcare Epidemiology of America) COVID-19 FAQ – Includes information regarding how a person under investigation for COVID-19 should be managed, specifically as it relates to phlebotomy and the laboratory

CDC Laboratory Job Aids – Features laboratory preparedness and safety job aids relevant to COVID-19, including a video job aid about safely donning and doffing PPE.

CDC Laboratory Training – Includes laboratory preparedness, PPE, and safety laboratory trainings relevant to COVID-19.

Laboratory Preparedness, Personal Protective Equipment (PPE), and Safety Updates

CDC LOCS Lab Advisory: CDC Publishes New General Laboratory Safety Guidance (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Alert: DOT Issues Safety Notice for Transportation of COVID-19 Diagnostic Samples (CDC LOCS (Laboratory Outreach Communication System) Lab Alert)

CDC LOCS Lab Advisory: CDC Updates Laboratory Biosafety Guidelines and Questions & Answers (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Alert: Molecular Transport Media (MTM) and Cyanide Gas (CDC LOCS (Laboratory Outreach Communication System) Lab Alert)

CDC LOCS Lab Advisory: CDC Posts Updated Point-of-Care Testing Biosafety Guidelines for COVID-19 (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

The Joint Commission Statement on Universal Masking of Staff, Patients, and Visitors in Health Care Settings (The Joint Commission statement)

NIH Study Validates Decontamination Methods for Re-use of N95 Respirators (NIH media advisory)

Joint Commission Statement on Use of Face Masks Brought From Home (The Joint Commission statement)

"Shortages of Personal Protective Equipment in the COVID-19 Pandemic” (post from The Joint Commission Leading Hospital Improvement blog)

"Managing Critical Shortages of Personal Protective Equipment" (post from The Joint Commission On Infection Prevention & Control blog)

Clinical Collections

CDC COVID-19 Information for Laboratories webpage

CDC Laboratory Outreach Communication System (LOCS) webpage – Links to recent LOCS communications relating to COVID-19

CDC Information for Healthcare Professionals about Coronavirus (COVID-19) webpage

CDC Preparing and Supporting Laboratories Responding to COVID-19 webpage

FDA COVID-19 webpage

CMS Current Emergencies webpage

WHO COVID-19 webpage - Includes situation reports and Strategic Preparedness and Response Plan

WHO EPI-WIN (Information Network for Epidemics)

The Joint Commission COVID-19 webpage - Includes a section specific to laboratory services

Other Clinical Resources

Free Course on Pandemic Preparedness

Pathologists Overseas COVID Testing Dashboard

UW Medicine COVID-19 Resource Site

Jennifer Kasten, MD, MSc, MSc, FASCP, Facebook page - Ongoing analysis of the COVID-19 pandemic provided by Dr. Kasten via her Facebook page

Payments & Reporting Resources

Payment and Reporting Resources

CMS Current Emergencies webpage 

CDC Reporting Lab Data webpage

LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests

Data and Dashboards

CDC COVID Data Tracker

Johns Hopkins University Center for Systems Science and Engineering COVID-19 Global Cases dashboard

Payment and Reporting Updates

CDC LOCS Lab Advisory: Guidance for LOINC In-Vitro Diagnostic (LIVD) Code Selection for Laboratories Using Laboratory-Developed Tests (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: Update on COVID-19 Laboratory Reporting Requirements (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: Updated LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: HHS Issues New CARES Act Guidance (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing (HHS press release)

CDC LOCS Lab Advisory: New COVID-19 Data Tracker Website for Laboratories (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

COVID-19: Modified Ordering Requirements for Laboratory Billing (MLN Connects - Official CMS News from the Medicare Learning Network® (MLN))

CDC LOCS Lab Advisory: Updated LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CDC LOCS Lab Advisory: New LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results (CDC LOCS (Laboratory Outreach Communication System) Lab Advisory)

CMS Increases Medicare Payment for High-Production Coronavirus Lab Tests (CMS press release)

Trump Administration Provides Financial Relief for Medicare Providers (CMS press release)

CMS Open Payments COVID-19 Announcement (CMS FAQs)

CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19 (CMS press release)

Career Resources

ASCP Career Center

The ASCP Career Center provides the most up-to-date job opportunities as well a place where jobseekers can set up a job profile that employers can find.


Access ASCP Career Center

ASCP Mentorship Program

The ASCP Mentorship Program connects ASCP members for professional guidance and support. The mentorship program connects individuals with specific skills and experience (mentors) with individuals looking to grow in their careers by learning from others (mentees).

Learn More

Data on Laboratory Staffing During the COVID-19 Pandemic

View the results of a recent ASCP survey to learn more about changes in testing, staffing, and retention of laboratory professionals during the COVID-19 pandemic.

Learn More

Free Course on Burnout

During this challenging time, ASCP is offering free access to an ASCP Leadership Institute course on burnout prevention, management, and resources.

Learn More

Grant Resources

National Institutes of Health Funding Announcements and Notices of Special Interest

Funding Announcements

Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-AG-21-035)

Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (PAR-21-213)

NIH: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) (RFA-AA-21-003)

NIH: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) (RFA-AA-21-002)

NIH: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) (RFA-AA-21-004)

NIH: Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) (RFA-AI-20-078)

NIH: Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) (RFA-AI-20-077)

NIH: Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) (PAR-20-178)

NIH: Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19

Notices of Special Interest

Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children (NOT-MH-21-225)

Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries (NOT-TW-21-004)

Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards (NOT-TW-21-003)

Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations (NOT-NS-21-037)

Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy (NOT-GM-21-032)

Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19 (NOT-OD-21-071)

Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy (NOT-GM-21-021)

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs (NOT-TR-21-022)

Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration (NOT-AG-21-016)

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-21-019)

Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies (NOT-GM-21-031)

Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation (NOT-MD-21-012)

Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders (NOT-DA-21-018)

Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control (NOT-CA-21-033)

Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs (NOT-TR-21-017)

Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) NOT-AA-21-003)

Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) (NOT-AA-21-001)

Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) (NOT-DE-21-001)

Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders (NOT-DA-21-019)

Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 (NOT-DA-21-017)

Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) (NOT-AI-21-008)

Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-21-012)

Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research (NOT-MH-21-120)

Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs (NOT-TR-21-011)

Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects (NOT-AI-21-002)

Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID19 infection (NOT-DA-20-084)

Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract (NOT-HD-20-021)

Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) (NOT-HL-20-814)

Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19) (NOT-MH-20-061)

Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" (NOT-NS-20-074) 

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051)

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI- supported Projects to be Redirected to COVID-19-related Research During the Crisis (NOT-CA-20-054)

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-AG-20-022)

Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (NOT-AA-20-011)

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-017)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-016)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NOT-MH-20-047)

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-015)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)

Funding Announcements from Other Federal Agencies

CDC: National Initiative to Address COVID-19 Health Disparities

Biomedical Advanced Research and Development Authority (BARDA)

Biomedical Advanced Research and Development Authority: Mask Innovation Challenge: Building Tomorrow’s Mask

CDC: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

EPA: Environmental Justice Small Grants Program

U.S. Department of State: 2020 TIP Office Annual Program Statement to Address Impacts of COVID-19

HHS: Community Health Workers for COVID Response and Resilient Communities (CCR) Evaluation and Technical Assistance (ETA); CCR-ETA Forecast 1

CDC: Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality

HHS: Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) (PAR-20-177)

NSF: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

NSF: Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)

DOE: Invitation for COVID-19 Scientific Questions (DOE Resources)

USAID/Bangladesh and the Private Sector: Partnering to Fight COVID-19

Non-federal Grant Announcements

COVID-19 Early Treatment Fund (CETF): Outpatient Trials for Repurposed Drugs

Patient-Centered Outcomes Research Institute: Engagement Awards Special Cycles Launch for Projects on COVID-19, IDD

International Research Development Centre: Women’s Economic Empowerment in a Low-Carbon COVID-19 Recovery

Stop the Spread

Global Innovation Fund: COVID-19 Response

Pfizer: COVID-19 General Research Grants

King Badouin Foundation: Sofina COVID Solidarity Fund

American Lung Association: COVID-19 and Emerging Respiratory Viruses Research Award

Boehringer lngelheim: IIS Program

Innovations for Poverty Action: Peace & Recovery Program: COVID-19 Off-Cycle Funding

Biogen Foundation: COVID-19 Relief

Draper Richards Kaplan: Covid-19 Urgent Response Initiative

Robert Wood Johnson Foundation: Pioneering Ideas: Exploring the Future to Build a Culture of Health

Amgen Foundation: COVID-19 Relief Support

Fast Grants: Fast Funding for COVID-19 Science

California Institute for Regenerative Medicine (CIRM)

Open Road Alliance

Bill & Melinda Gates Foundation, Wellcome and Mastercard: COVID-19 Therapeutics Accelerator

Events & Recordings

ASCP Virtual Town Hall Series

In these uncertain times ASCP wants to ensure that all pathologists and laboratory professionals have the resources needed to take a leading role on the medical team. To help you through the challenges you are facing, ASCP has launched a new Virtual Town Hall Series. This series will address the main concerns affecting the laboratory team during this crisis and beyond. Visit the ASCP Virtual Town Hall Series webpage to access past town hall recordings and find information on upcoming town halls.

Access Virtual Town Hall Series

Inside the Lab Podcast

Inside the Lab is ASCP’s podcast focusing on current topics, such as COVID-19, showcasing the everyday laboratory professional and pathologist. The podcast’s goal is to generate thought-provoking discussions about topics relevant to the field of pathology and laboratory medicine.

Access Inside the Lab

Other Upcoming Events

FDA Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests (virtual events, on-demand presentations and transcripts)

CDC Clinical Laboratory COVID-19 Response Calls (virtual events, on-demand transcripts and recordings)

CMS COVID-19 Stakeholder Engagement Calls (virtual events, on-demand transcripts and recordings)

Share Your Story!

Help ASCP capture and document the vital contributions pathologists and laboratory professionals are making towards patient care during the fight against the COVID-19 pandemic. Submit your story as a part of our "COVID-19: Medical Diagnostic Team" initiative.


Submit Story
  • My Role
    • Pathologist
    • Resident
    • Lab Professional
    • Program Directors
    • Student
  • Membership
    • Renew Membership
    • Become a Member
    • Get Involved
    • Rewards
    • Member Center
  • Learning
    • Certificate Programs
    • Attend Meetings
    • Explore Books and Journals
    • Continuous Quality Improvement & Quality Assurance
    • Access My Education
    • ACCME
    • CC Resources
    • CMP Resources
    • ASCPedia
    • Featured Education
    • Immuno-Oncology
    • ASCP Annual Meeting
    • ASCP Virtual Town Hall Series
    • Inside the Lab
  • Get Involved
    • Get Recognized
    • Receive Awards
    • Serve Your Community
    • Center for Global Health
    • Serve Your Profession
    • Partners in Cancer Diagnosis
    • Institute for Science Technology & Public Policy
    • Choosing Wisely
    • Patient Champions
    • Discover Opportunities
    • Apply to Volunteer
    • Ambassadors
    • ASCP Mentorship Program
  • Careers
    • Find a Job
    • Post a Job
    • Learn About Careers
    • Discover Fellowships
    • Work at ASCP
  • About ASCP
    • Our Mission
    • Supporting Our Members
    • Our Community Efforts
    • ASCP Foundation
    • Contact ASCP
    • Media Relations
  • Board of Certification
    • Get Credentialed
    • Stay Credentialed
    • Verify Credentials
    • Program Directors
    • About BOC
    • Apply Now/Check Status/Update Info
    • Manage Your BOC Account
    • Declaration & Complete CMP
  • News
    • ePolicy News
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021 by American Society for Clinical Pathology. All Rights Reserved.